AL
ACOR

AJO LP’s Acorda Therapeutics ACOR Stock Holding History

AJO LP’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-265
Closed -$667K – 653
2017
Q1 		$667K Sell
265
-6
-2% -$17.3K ﹤0.01% 461
2016
Q4 		$610K Sell
271
-136
-33% -$323K ﹤0.01% 452
2016
Q3 		$1.02M Sell
407
-757
-65% -$2.26M ﹤0.01% 400
2016
Q2 		$3.56M Sell
1,164
-4,103
-78% -$13.3M 0.02% 295
2016
Q1 		$16.7M Buy
+5,267
New +$21.9M 0.07% 190
2014
Q3 		– Sell
-87
Closed -$351K – 486
2014
Q2 		$351K Hold
87
– – ﹤0.01% 413
2014
Q1 		$394K Buy
+87
New +$352K ﹤0.01% 370

Other funds holding ACOR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

AJO LP's ACOR Position: Q2 2017 in Review

AJO LP sold out of Acorda Therapeutics (ACOR) in Q2 2017, closing a stake of 265 shares — an estimated $667K sold.

AJO LP first reported a position in ACOR in Q1 2014 and held it in 7 quarters. The position peaked at $16.7M in Q1 2016. 151 funds tracked by Wall St. Rank hold ACOR as of Q2 2017.

  • AJO LP reported no remaining Acorda Therapeutics position as of Q2 2017 after selling out during the quarter.
  • AJO LP sold 265 Acorda Therapeutics shares in Q2 2017, an estimated $667K.
  • AJO LP first reported a position in Acorda Therapeutics in Q1 2014 and held it in 7 quarters.
  • AJO LP's Acorda Therapeutics position peaked at $16.7M in Q1 2016.
  • 151 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2017.

Based on AJO LP's 13F filing for Q2 2017, filed 10 Aug 2017.